|
Real-time Estimate
Cboe BZX
11:44:27 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 6.935 USD | +0.07% |
|
-40.12% | -61.78% |
| 10-23 | Avalo Therapeutics Shares Fall After HC Wainwright Downgrade | MT |
| 10-23 | Guggenheim Downgrades Avalo Therapeutics to Neutral From Buy | MT |
Stock exchange
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-10-20 | 2026-10-21 | 2026-10-22 | 2026-10-23 | 2026-10-26 | |
|---|---|---|---|---|---|
| Last | US$12.36 | US$12.26 | US$7.450 | US$6.930 | US$6.930 |
| Volume | 1,869,562 | 930,224 | 26,189,975 | 4,551,356 | 527,622 |
| Change | +6.64% | -0.81% | -39.23% | -6.98% | +0.07% |
| Opening | US$11.61 | US$12.41 | US$8.990 | US$7.270 | US$6.820 |
| High | US$12.85 | US$13.18 | US$9.350 | US$7.500 | US$7.130 |
| Low | US$11.26 | US$12.22 | US$6.850 | US$6.530 | US$6.720 |
Performance
| 1 day | -0.51% | ||
| 1 week | -40.12% | ||
| Current month | -54.73% | ||
| 1 month | -53.98% | ||
| 3 months | -64.41% | ||
| 6 months | -51.87% | ||
| Current year | -61.78% | ||
| 1 year | -61.42% | ||
| 3 years | -72.35% | ||
| 5 years | -99.89% | ||
| 10 years | -99.94% |
Volumes
marketsDaily volume
527,622
Estimated daily volume
1,721,466
Avg. Volume 20 sessions
3,007,325
Daily volume ratio
0.57
Avg. Volume 20 sessions USD
20,855,798.88
Record volume 1
31,910,412
Record volume 2
26,189,975
Record volume 3
22,460,588
Capital turnover ratio
0.06
Float rotation
0.06
Basic data
Market Cap (USD)
371,655,823
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
98.31%
Free-Float capitalization (USD)
365,380,161
Average Daily Capital Traded
5.61%
Indicators
Moving average 5 days
10.12
Moving average 20 days
13.21
Moving average 50 days
16.31
Moving average 100 days
16.81
Price spread / (MMA5)
+45.90%
Price spread / (MMA20)
+90.54%
Price spread / (MMA50)
+135.16%
Price spread / (MMA100)
+142.42%
STIM
RSI 9 days
14.91
RSI 14 days
18.08
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | -40.12% | -61.42% | -72.35% | 372M | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| +0.28% | +7.51% | +10.41% | +78.36% | 54.78B | |
| +0.47% | +3.10% | +9.26% | +100.13% | 53.49B | |
| +0.25% | +5.43% | +28.92% | +52.00% | 45.98B | |
| -0.82% | +1.05% | +18.58% | +125.54% | 42.94B | |
| -1.14% | +1.79% | +219.73% | +831.24% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.86% | +17.51% | +59.73% | +47.29% | 23.67B | |
| Average | +1.02% | -1.85% | +36.78% | +128.28% | 38.35B | |
| Weighted average by Cap. | +0.69% | +2.55% | +44.78% | +151.79% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e143ecd6fe828796c7ac0ccea12f07e.fm95mV7cGvBzPv9YJ8EKg0RBaa91yOJeq-nAXyeP1dg.JhcU6gmPL7QKCM45VrJd4SkFBPo_urc7z6SGbnPsu75IGDHXGZRFoEFNzw
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:29:23 | 6.930 | 114 | 436,406 |
| 11:29:21 | 6.930 | 100 | 436,292 |
| 11:29:21 | 6.930 | 240 | 436,192 |
| 11:29:21 | 6.930 | 100 | 435,952 |
| 11:29:21 | 6.930 | 100 | 435,852 |
| 11:29:21 | 6.930 | 100 | 435,752 |
| 11:29:19 | 6.930 | 100 | 435,652 |
| 11:29:19 | 6.930 | 100 | 435,552 |
| 11:29:19 | 6.930 | 100 | 435,452 |
| 11:29:19 | 6.930 | 100 | 435,352 |
Price Extremes
| 1 week | 6.53 |  | 13.18 |
| 1 month | 6.53 | | 15.99 |
| Current year | 6.53 | | 24.27 |
| 1 year | 6.53 | | 24.27 |
| 3 years | 3.39 | | 34.46 |
| 5 years | 3.39 | | 7,055.95 |
| 10 years | 3.39 | | 22,031.54 |
Monthly variations
Annual variations
| 2026 | -61.84% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
